MINERALYS THERAPEUTICS INC
MLYS·603170101·US·Common Stock·Healthcare - Biotechnology-Activist
MLYS (MINERALYS THERAPEUTICS INC) is held by 114 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($208.4M), FMR LLC ($131.7M), BlackRock, Inc. ($121.4M). Net institutional sentiment: Mixed.
114
Holders
(7 Elite)
$1.4B
Total Value
62% (116)
Consensus
72 buying - 44 selling
13F: Insider & Congress:
Who's Trading
InsiderRMRodman David MalcomSell $169KJul 15, 2026
InsiderCJCongleton JonSell $291KJul 13, 2026
InsiderRMRodman David MalcomSell $388KJul 13, 2026
InsiderRMRodman David MalcomSell $66KJul 9, 2026
InsiderCJCongleton JonSell $1.5MJun 30, 2026
InsiderCJCongleton JonSell $456KJun 30, 2026
InsiderWEWarren EricSell $2.7MJun 26, 2026
InsiderRMRodman David MalcomSell $13KApr 17, 2026
ActivistCPCatalys Pacific Fund, LP10.1%Feb 13, 2026
Showing 1-20 of 123
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer